Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6700
-0.0100 (-1.47%)
Feb 5, 2026, 3:52 PM AEST
Aroa Biosurgery Revenue
Aroa Biosurgery had revenue of 44.86M NZD in the half year ending September 30, 2025, with 40.75% growth. This brings the company's revenue in the last twelve months to 90.40M, up 18.40% year-over-year. In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M with 22.63% growth.
Revenue (ttm)
90.40M NZD
Revenue Growth
+18.40%
P/S Ratio
2.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
231.47M AUD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.70M | 15.63M | 22.63% |
| Mar 31, 2024 | 69.07M | 5.71M | 9.01% |
| Mar 31, 2023 | 63.36M | 23.68M | 59.68% |
| Mar 31, 2022 | 39.68M | 17.34M | 77.60% |
| Mar 31, 2021 | 22.34M | -2.73M | -10.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 128.70M |
| SomnoMed | 111.49M |
| Compumedics | 51.04M |
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Lumos Diagnostics Holdings | 18.91M |
| Micro-X | 13.05M |
| EMVision Medical Devices | 5.05M |
Aroa Biosurgery News
- 1 year ago - Aroa Biosurgery Ltd (ASX:ARX) H1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus